|
RAD51L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.811600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.040170E-01 |
| Normal-vs-Stage2 |
2.356300E-03 |
| Normal-vs-Stage3 |
3.339700E-02 |
| Normal-vs-Stage4 |
6.281000E-01 |
| Stage1-vs-Stage2 |
2.842000E-02 |
| Stage1-vs-Stage3 |
3.850000E-01 |
| Stage1-vs-Stage4 |
4.152600E-01 |
| Stage2-vs-Stage3 |
9.642200E-02 |
| Stage2-vs-Stage4 |
1.636420E-02 |
| Stage3-vs-Stage4 |
1.512010E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.525900E-02 |
| Normal-vs-AfricanAmerican |
9.332800E-01 |
| Normal-vs-Asian |
4.177000E-01 |
| Caucasian-vs-AfricanAmerican |
2.112200E-01 |
| Caucasian-vs-Asian |
5.929800E-01 |
| AfricanAmerican-vs-Asian |
5.217800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.200800E-03 |
| Normal-vs-Female |
2.121600E-01 |
| Male-vs-Female |
1.774040E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.630600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.609800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.316400E-03 |
| Normal-vs-Age(81-100Yrs) |
8.997800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.483400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.037940E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.992600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.777500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.955600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.962240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.382000E-01 |
| Classical-VS-Follicular |
7.34540206437373E-11 |
| Classical-VS-Other |
9.738800E-01 |
| Classical-VS-Normal |
6.832400E-01 |
| Tall-VS-Follicular |
1.75516999999514E-05 |
| Tall-VS-Other |
8.814000E-01 |
| Tall-VS-Normal |
9.048200E-01 |
| Follicular-VS-Other |
2.720200E-02 |
| Follicular-VS-Normal |
1.9559999997476E-07 |
| Other-VS-Normal |
8.363200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.777400E-04 |
| Normal-vs-N1 |
5.222000E-01 |
| N0-vs-N1 |
2.516100E-02 |
|
|
